Proteogenomic insights suggest druggable pathways in endometrial carcinoma
Yongchao Dou(Baylor College of Medicine), Mehdi Mesri(National Cancer Institute), Rafał Matkowski(Wroclaw Medical University), Yi-Ting Wang(Pacific Northwest National Laboratory), Eunkyung An(National Cancer Institute), Isabelle Johnson(Institute for Systems Biology), Rosalie Chu(Pacific Northwest National Laboratory), Ramya P. Masand(Washington University in St. Louis), Andrea G. Kahn(University of Alabama at Birmingham), Paweł Kurzawa(Poznan University of Medical Sciences), McKenzie E. Foxall(University of Alabama at Birmingham), Rossana Lazcano(The University of Texas MD Anderson Cancer Center), John A. Martignetti(Cancer Clinic), Scott D. Jewell(Van Andel Institute), Rebecca C. Arend(University of Alabama at Birmingham), Elizabeth G. Demicco(Harvard University), Catherine Hermann(Gynecologic Oncology Group), Jasmin Bavarva, Alexander J. Lazar(The University of Texas MD Anderson Cancer Center), Thomas Fillmore(Pacific Northwest National Laboratory), Jonathan T. Lei(Baylor College of Medicine), Yingwei Hu(Johns Hopkins University), Amy T. Ku(Baylor College of Medicine), Yuxing Liao(Baylor College of Medicine), Galen Hostetter(Van Andel Institute), Teresa Davoli(NYU Langone Health), Andrzej Czekański(Wroclaw Medical University), Rita Jui-Hsien Lu(James S. McDonnell Foundation), Chia‐Feng Tsai(Pacific Northwest National Laboratory), Iga Kołodziejczak(Medical University of Warsaw), Peter R. Dottino(Icahn School of Medicine at Mount Sinai), Marcin Jędryka(Lublin Oncology Center), Deborah F. DeLair(NYU Langone Health), T. Mamie Lih(Johns Hopkins University), Boris Reva(Memorial Sloan Kettering Cancer Center), Tara Hiltke(National Cancer Institute), Saravana M. Dhanasekaran(University of Michigan), Runyu Hong(Institute for Systems Biology), Kelly A. Devereaux(New York University), Lijun Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Chandan Kumar‐Sinha(Indira Gandhi Institute of Medical Sciences), Yi Li(Shanghai University of Traditional Chinese Medicine), Xiaofang Guo(University of South Florida), Wenke Liu(Chongqing Technology and Business University), Wilson McKerrow(Memorial Sloan Kettering Cancer Center), Bailee Dover(University of Alabama at Birmingham), Lizabeth Katsnelson(Institute for Systems Biology), Tai‐Tu Lin(Pacific Northwest National Laboratory), Wen Bu(Baylor College of Medicine)
Cited by 53
Related Papers
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
|Journal of Clinical Oncology|2018|925